Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout
- PMID: 33426901
- PMCID: PMC8009810
- DOI: 10.1177/1740774520982315
Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout
Abstract
Background: Missing data are a notable problem in Alzheimer's disease clinical trials. One cause of missing data is participant dropout. The Research Attitudes Questionnaire is a 7-item instrument that measures an individual's attitudes toward biomedical research, with higher scores indicating more favorable attitudes. The objective of this study was to describe the performance of the Research Attitudes Questionnaire over time and to examine whether Research Attitudes Questionnaire scores predict study dropout and other participant behaviors that affect trial integrity.
Methods: The Research Attitudes Questionnaire was collected at baseline and weeks 26 and 52 from each member of 119 participant/study partner dyads enrolled in a Phase 2, randomized, double-blind, placebo-controlled mild-to-moderate Alzheimer's disease clinical trial. Within-subject longitudinal analyses examined change in Research Attitudes Questionnaire scores over time in each population. Logistic regression analyses that controlled for trial arm and clustering in trial sites were used to assess whether baseline Research Attitudes Questionnaire scores predicted trial completion, study medication compliance, and enrollment in optional substudies.
Results: Participants and study partners endorsed statistically similar ratings on the Research Attitudes Questionnaire that were stable over time. Participants with baseline Research Attitudes Questionnaire scores above 28.5 were 4.7 (95% confidence interval = 1.01 to 21.95) times as likely to complete the trial compared to those with lower scores. Applying the same cutoff, baseline study partner Research Attitudes Questionnaire scores were similarly able to predict study completion (odds ratio = 4.2, 95% confidence interval = 1.71 to 10.32). Using a score cutoff of 27.5, higher participant Research Attitudes Questionnaire scores predicted study medication compliance (odds ratio = 5.85, 95% confidence interval = 1.34 to 25.54). No relationship was observed between Research Attitudes Questionnaire score and participation in optional substudies.
Conclusion: This brief instrument that measures research attitudes may identify participants at risk for behaviors that cause missing data.
Trial registration: ClinicalTrials.gov NCT01504854.
Keywords: Dropout; missingness; retention.
Figures
Similar articles
-
To attend, or not to attend: Examining caregiver intentions and study compliance in a pediatric, randomized controlled trial.Clin Trials. 2020 Apr;17(2):223-230. doi: 10.1177/1740774519893307. Epub 2020 Jan 27. Clin Trials. 2020. PMID: 31984781 Free PMC article.
-
Quantification of disease progression and dropout for Alzheimer's disease.Int J Clin Pharmacol Ther. 2013 Feb;51(2):120-31. doi: 10.5414/CP201787. Int J Clin Pharmacol Ther. 2013. PMID: 23211395
-
Utilization of Observational Data as a Proxy Cohort for Comparison Purposes with Open-Label Study Results: An Example from Alzheimer's Disease.J Prev Alzheimers Dis. 2019;6(2):90-99. doi: 10.14283/jpad.2019.4. J Prev Alzheimers Dis. 2019. PMID: 30756115
-
ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.Alzheimers Res Ther. 2016 Oct 18;8(1):44. doi: 10.1186/s13195-016-0210-1. Alzheimers Res Ther. 2016. PMID: 27756421 Free PMC article. Clinical Trial.
-
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5. Trials. 2021. PMID: 33430924 Free PMC article.
Cited by
-
Research attitudes in families of individuals with Down syndrome: importance for clinical trials.Alzheimers Res Ther. 2022 Nov 23;14(1):176. doi: 10.1186/s13195-022-01120-6. Alzheimers Res Ther. 2022. PMID: 36419175 Free PMC article.
-
Research Attitude and Interest among Cancer Survivors with or without Cognitive Impairment.Cancers (Basel). 2023 Jun 29;15(13):3409. doi: 10.3390/cancers15133409. Cancers (Basel). 2023. PMID: 37444519 Free PMC article.
-
Measurement invariance of the Research Attitudes Questionnaire in an age and ethnically diverse, community-dwelling sample.J Alzheimers Dis Rep. 2025 Jul 29;9:25424823251361513. doi: 10.1177/25424823251361513. eCollection 2025 Jan-Dec. J Alzheimers Dis Rep. 2025. PMID: 40755856 Free PMC article.
-
Impaired autophagy in amyloid-beta pathology: A traditional review of recent Alzheimer's research.J Biomed Res. 2022 Sep 28;37(1):30-46. doi: 10.7555/JBR.36.20220145. J Biomed Res. 2022. PMID: 36642915 Free PMC article.
-
Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer's Disease Randomized Controlled Trial.J Prev Alzheimers Dis. 2024;11(4):874-880. doi: 10.14283/jpad.2024.136. J Prev Alzheimers Dis. 2024. PMID: 39044496 Free PMC article. Clinical Trial.
References
-
- Angst J, Bech P, Bobon D, et al. Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs. Pharmacopsychiatry 1991; 24: 149–152. 1991/September/01. - PubMed
-
- Gross RA and Johnston KC. Levels of evidence: Taking Neurology to the next level. Neurology 2009; 72: 8–10. - PubMed
-
- Gardette V, Coley N, Toulza O, et al. Attrition in geriatric research: how important is it and how should it be dealt with? The journal of nutrition, health & aging 2007; 11: 265–271. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical